Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide for mild-to-moderate COVID-19
NCT04330586Phase 2Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ciclesonide in coronavirus disease 2019 (COVID-19), sponsored by Korea University Guro Hospital. Started Apr 2020; status: completed.
02
Drugs
ciclesonide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04330586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04330586.